Dryen Pharmaceuticals Private Limited
About Dryen Pharmaceuticals Private Limited
Data last updated:
Dryen Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2018PTC104212. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yogesh Samar Singh (Managing Director) and Brijesh Kumar Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at C & S 127 129 Patel Nagar Godadara, Surat, Gujarat, India – 395006.
As per the financials filed for FY 2021, the company reported a revenue of ₹3.48 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹3.04 Lakh (net margin -87.4%) and EBITDA of -₹3.03 Lakh (EBITDA margin -87%).
Company details
Contact details
Dryen Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressC & S 127 129 Patel Nagar Godadara, Surat, Gujarat, India – 395006
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Dryen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dryen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dryen Pharmaceuticals Private Limited, buy the company report.
Financials of Dryen Pharmaceuticals Private Limited
FY 2021 filings availableDryen Pharmaceuticals Private Limited reported revenue of ₹3.48 Lakh (down 76% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 76% in the latest year. EBITDA rose 20% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3.03 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.04 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -87% | ||
| Net Profit Margin | -87.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Dryen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dryen Pharmaceuticals Private Limited
Dryen Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijesh Kumar Singh | Whole-Time Director | 08 Oct 2018 | 8 Years 1 Months | Current |
| Yogesh Samar Singh | Managing Director | 21 Nov 2018 | 7 Years 11 Months | Current |
| Chetna Amulakhbhai Savani | Whole-Time Director | 29 Feb 2020 | 6 Years 8 Months | Current |
| Hiteshkumar Dhirajlal Lapsiwala | Whole-Time Director | 29 Feb 2020 | 6 Years 8 Months | Current |
| Prince Dineshbhai Desai | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Dryen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dryen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dryen Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Dryen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dryen Pharmaceuticals Private Limited has 11 board changes on record since 2018: 5 appointments and 6 cessations. The latest: Chetna Amulakhbhai Savani ceased to be Director on 21 Dec 2020.
2 earlier events are in the company report.
Frequently asked questions
Dryen Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U24230GJ2018PTC104212.
Dryen Pharmaceuticals has 5 current directors:
- Yogesh Samar Singh - Managing Director
- Brijesh Kumar Singh - Whole-Time Director
- Chetna Amulakhbhai Savani - Whole-Time Director
- Hiteshkumar Dhirajlal Lapsiwala - Whole-Time Director
- Prince Dineshbhai Desai - Director
The latest financial statements of Dryen Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
No. Dryen Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dryen Pharmaceuticals is U24230GJ2018PTC104212. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dryen Pharmaceuticals was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Chetna Amulakhbhai Savani ceased to be Director on 21 Dec 2020. Hiteshkumar Dhirajlal Lapsiwala ceased to be Director on 21 Dec 2020. Chetna Amulakhbhai Savani was appointed as Whole-Time Director on 29 Feb 2020. Dryen Pharmaceuticals has 11 board changes on record in total.
The registered office of Dryen Pharmaceuticals is at C & S 127 129 Patel Nagar Godadara, Surat, Gujarat, India – 395006.
Dryen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Dryen Pharmaceuticals can be reached at its registered office: C & S 127 129 Patel Nagar Godadara, Surat, Gujarat, India – 395006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
